Amarin Corporation
AMRN
#8357
Rank
A$0.41 B
Marketcap
A$19.73
Share price
-0.93%
Change (1 day)
-16.83%
Change (1 year)

Earnings for Amarin Corporation (AMRN)

Earnings in 2026 (TTM): -A$46.6 Million

According to Amarin Corporation 's latest financial reports the company's current earnings are A$0.21 Billion. In 2025 the company made an earning of -A$51.54 Million, an increase over its 2024 earnings that were of -A$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amarin Corporation from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$46.6 Million-9.58%
2025 -A$51.54 Million-53.31%
2024 -A$0.12 Billion43.84%
2023 -A$76.74 Million-48.3%
2022 -A$0.15 Billion-1019.36%
2021 A$16.14 M-165.44%
2020 -A$24.67 Million-23.25%
2019 -A$32.15 Million-80.68%
2018 -A$0.17 Billion112.25%
2017 -A$78.38 Million-28.23%
2016 -A$0.11 Billion-35.43%
2015 -A$0.17 Billion99.81%
2014 -A$84.64 Million-65.06%
2013 -A$0.25 Billion-0.38%
2012 -A$0.25 Billion-150.87%
2011 A$0.47 B-233.68%
2010 -A$0.36 Billion
2007 -A$55.81 Million44.04%
2006 -A$38.75 Million
2004 -A$20.94 Million-46.41%
2003 -A$39.07 Million-41.09%
2002 -A$66.31 Million813.31%
2001 -A$7.27 Million113.63%
2000 -A$3.4 Million
1998 -A$24.17 Million98.82%
1997 -A$12.16 Million-50.29%
1996 -A$24.45 Million-1321.43%
1995 A$2 M-94.53%
1994 A$36.6 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
A$8.54 B-19,287.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.96 B-47,190.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.31 B-32,249.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
A$0.33 B-861.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$3.24 B-7,392.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel